AMS

AMS

USD

American Shared Hospital Services Common Stock

$2.750+0.000 (0.000%)

Reaalajas hind

Healthcare
Medical Care Facilities
Ameerika Ühendriigid

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$2.750

Kõrge

$2.790

Madal

$2.719

Maht

0.00M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

18.2M

Tööstusharu

Medical Care Facilities

Riik

United States

Kauplemisstatistika

Keskmine maht

0.02M

Börs

ASE

Valuuta

USD

52 nädala vahemik

Madal $2.51Praegune $2.750Kõrge $4.6

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 17. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

[AMS: American Shared Hospital Services Common Stock]: Checking the Pulse - What's Happening & What to Watch

Stock Symbol: AMS Generate Date: 2025-04-17 02:12:13

Alright, let's take a look at American Shared Hospital Services (AMS). For folks who aren't glued to stock tickers all day, this company is in the healthcare business, specifically dealing with fancy medical equipment like radiosurgery tools for cancer treatment. So, what's the story lately?

Recent News Buzz: Quietly Busy

The news feed for AMS isn't exactly screaming headlines, but it's showing some activity. We've got announcements about their upcoming shareholder meeting in June – standard company housekeeping. They're also presenting at a microcap conference in Vegas, which is interesting. It suggests they're actively trying to get in front of investors, maybe to drum up some interest. Crucially, there's news about their full year 2024 financial results, including the appointment of a new CEO. This is probably the most significant piece – changes at the top often signal shifts in strategy or direction. Overall, the news isn't negative, but it's not wildly exciting either. Think of it as a company keeping things ticking over, with a bit of a leadership change in the mix.

Price Check: A Bit of a Dip Lately

Now, let's peek at the stock price action over the last month or so. If you glance at the numbers, you'll see a general drift downwards. Back in mid-January, we were seeing prices around $3.10 - $3.20. Fast forward to now, and we're closer to the $2.70 range. There was a bit of a sharper drop in early March, and while there have been a few bounces, the overall trend looks like it's been leaning downwards. The AI prediction for the very short term (today and the next couple of days) is suggesting a slight upward nudge, but nothing dramatic. Compared to its 52-week range ($2.51 to $4.60), the stock is currently closer to the lower end. It's not crashing, but it's definitely not on a hot streak right now.

Outlook & Ideas: Wait and See, But Keep an Eye Out?

So, putting it all together, what are we looking at? The news is neutral to slightly positive (new CEO, investor presentations), but the recent price action has been a bit soft. The AI is hinting at a tiny bump upwards soon, but it's not a strong signal.

Given this picture, the situation doesn't scream "jump in and buy!" right away. It might be more of a "hold your horses and watch" scenario for now. The stock has been trending down, and while there's some positive recommendation data out there (pointing to "Bullish Momentum" and being "Undervalued"), it's important to be cautious.

Potential Entry Consideration? If you were interested in AMS, and the slight AI predicted uptick actually materializes and the price starts to show some real upward momentum, then maybe watching for a move back towards the $2.75 - $2.80 area could be interesting. This is just above the current price and might suggest a bit of a turnaround is starting. However, this is purely speculative based on very short-term AI predictions and needs to be confirmed by actual price movement.

Potential Exit/Stop-Loss Consideration? On the flip side, if the downward trend resumes, a stop-loss somewhere below the recent lows, perhaps around $2.50, could be a way to manage risk. This level is just below the 52-week low and would signal further weakness if broken. For potential profit taking, if the stock does bounce, the AI recommendation mentions a take-profit around $2.80. Again, these are just potential levels to consider for risk management, not guarantees.

Company Context Reminder: Remember, AMS is in a niche healthcare area – medical equipment leasing and radiosurgery. News and developments in the healthcare sector, particularly around cancer treatment technologies and hospital spending, will be important for this company.

In short: AMS isn't flashing any immediate "buy" signals right now based on this snapshot. It's more of a "keep it on the watchlist" situation. Watch for actual price action to confirm any potential turnaround, and be mindful of risk management if considering any moves.


Disclaimer: This analysis is for informational purposes only and should not be taken as financial advice. I'm just breaking down publicly available data and news. Investing in the stock market involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

GlobeNewswire

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer

Vaata rohkem
American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025
GlobeNewswire

American Shared Hospital Services to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub

SAN FRANCISCO, April 09, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer

Vaata rohkem
American Shared Hospital Services to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub
GlobeNewswire

American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results

Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"),

Vaata rohkem
American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results
GlobeNewswire

American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery and advanced radiation therapy cancer treatment

Vaata rohkem
American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 28. apr 2025, 00:58

LangevNeutraalneTõusev

59.6% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
VäärtusKasv
Kauplemisjuhend

Sisenemispunkt

$2.70

Võta kasum

$2.97

Peata kahjum

$2.48

Põhitegurid

PDI 29.5 on MDI 25.0 kohal ADX-iga 8.6, mis viitab tõusutrendile
Praegune hind on tugitasemele ($2.73) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
MACD 0.0147 on signaalijoone 0.0165 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.